Verity Asset Management, Inc.

Position in IBRX — ImmunityBio, Inc.

CIK 1597298 DURHAM, NC

Position in IBRX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$847,501

+$320,174 QoQ

Shares Held

96,802

+40.8% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#122

of 401 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Verity Asset Management, Inc. holds $5,917,073 across 4 Biotechnology names. IBRX ranks #2 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	55,508	$4,344,611
2	IBRX	ImmunityBio, Inc. This page	96,802	$847,501
3	MDGL	Madrigal Pharmaceuticals, Inc.	1,252	$672,261
4	ATAI	AtaiBeckley Inc.	10,000	$52,700

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$847,501	96,802	+40.8%	Shares	Sole	2026-08-13
2026-03-31	$527,327	68,752	—	Shares	Sole	2026-04-21
No filing history on record for this holder in this stock.